X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1315) 1315
Newsletter (127) 127
Publication (91) 91
Book Review (22) 22
Newspaper Article (17) 17
Magazine Article (15) 15
Book Chapter (10) 10
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
finasteride (1078) 1078
male (896) 896
humans (781) 781
index medicus (453) 453
animals (325) 325
middle aged (320) 320
finasteride - administration & dosage (312) 312
prostatic hyperplasia - drug therapy (269) 269
finasteride - therapeutic use (262) 262
men (254) 254
urology & nephrology (248) 248
aged (246) 246
benign prostatic hyperplasia (225) 225
testosterone (207) 207
prostate (206) 206
female (203) 203
adult (201) 201
5-alpha reductase inhibitors (199) 199
pharmacology & pharmacy (198) 198
dutasteride (191) 191
finasteride - pharmacology (191) 191
prostate cancer (188) 188
rats (185) 185
treatment outcome (180) 180
research (173) 173
dosage and administration (146) 146
alopecia - drug therapy (144) 144
enzyme inhibitors - administration & dosage (142) 142
alopecia (135) 135
finasteride - adverse effects (132) 132
cancer (128) 128
dihydrotestosterone (127) 127
drug therapy (124) 124
care and treatment (123) 123
baldness (121) 121
enzyme inhibitors - therapeutic use (121) 121
antiandrogens (119) 119
hyperplasia (117) 117
androgens (115) 115
dose-response relationship, drug (111) 111
5-alpha reductase inhibitors - administration & dosage (110) 110
endocrinology & metabolism (110) 110
hypertrophy (109) 109
risk factors (109) 109
drug therapy, combination (108) 108
androgenetic alopecia (105) 105
enzyme inhibitors - pharmacology (102) 102
dermatology (99) 99
administration, oral (94) 94
therapy (94) 94
efficacy (93) 93
analysis (91) 91
prevention (90) 90
prostate - drug effects (90) 90
double-blind method (89) 89
health aspects (88) 88
time factors (87) 87
5-alpha-reductase inhibitor (86) 86
prostatic neoplasms - drug therapy (85) 85
mice (83) 83
testosterone - blood (83) 83
prostate - pathology (80) 80
prostatic neoplasms - prevention & control (80) 80
aged, 80 and over (77) 77
5-alpha reductase inhibitors - therapeutic use (75) 75
prostate-specific antigen - blood (75) 75
drug administration schedule (72) 72
rats, sprague-dawley (72) 72
expression (71) 71
neurosciences (70) 70
prostatic neoplasms - pathology (70) 70
oncology (69) 69
physiological aspects (67) 67
risk (67) 67
prostatic hyperplasia - complications (66) 66
5-alpha reductase inhibitors - adverse effects (65) 65
urology (64) 64
complications and side effects (63) 63
rats, wistar (63) 63
azasteroids - therapeutic use (62) 62
medicine, general & internal (62) 62
prospective studies (62) 62
follow-up studies (61) 61
prostatic hyperplasia - pathology (61) 61
adrenergic alpha-antagonists - administration & dosage (60) 60
dihydrotestosterone - blood (60) 60
drugs (60) 60
article (56) 56
doxazosin (56) 56
growth (56) 56
hair loss (56) 56
azasteroids - administration & dosage (54) 54
diagnosis (54) 54
medical research (54) 54
women (54) 54
adolescent (53) 53
5-alpha-reductase (52) 52
flutamide (52) 52
urinary-tract symptoms (52) 52
androgen antagonists - therapeutic use (51) 51
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1403) 1403
German (31) 31
Russian (14) 14
French (9) 9
Japanese (5) 5
Korean (4) 4
Danish (3) 3
Chinese (2) 2
Italian (2) 2
Polish (2) 2
Spanish (2) 2
Swedish (2) 2
Bulgarian (1) 1
Finnish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 08/2018, Volume 32, Issue 8, pp. 1373 - 1376
BackgroundIncidences of sexual dysfunction due to the use of 5 -reductase inhibitors have been suggested. Despite low sexual dysfunction reported in clinical... 
BENIGN PROSTATIC HYPERPLASIA | DISPROPORTIONALITY ANALYSIS | TRIALS | METAANALYSIS | MEN | FINASTERIDE | 5-ALPHA-REDUCTASE INHIBITORS | PHARMACOVIGILANCE | CANCER | DERMATOLOGY | Usage | Drug therapy | Sexual disorders | Analysis
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 02/2014, Volume 306, Issue 4, pp. E433 - E442
Journal Article
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 06/2018, Volume 45, Issue S19, pp. 377 - 377
Journal Article
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 11/2017, Volume 174, p. 48
* T serum levels regulate DHT serum levels by down-regulating the transcript levels of srd5a. * DHT triggers the onset of the meiotic phase of spermatogenesis.... 
Animal genetics | Testosterone | Finasteride | Cytochrome P-450 | Enzymes | RNA
Journal Article
Journal Article
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 08/2015, Volume 289, pp. 55 - 60
Acute stress has been demonstrated to alter sensory gating processes, measured by the prepulse inhibition of the startle response (PPI). It is well known that... 
Finasteride | Sensory gating | Neurosteroids | Acute swim stress | Allopregnanolone | Prepulse inhibition | PROGESTERONE | RAT STRAIN | SCHIZOPHRENIA | NEUROSTEROID LEVELS | NEUROSCIENCES | DEFICIENT | EXPLORATION | BEHAVIORAL SCIENCES | ANIMAL-MODEL | GABA(A) RECEPTORS | ACOUSTIC STARTLE | Antiandrogens
Journal Article